Verona Pharma (NASDAQ:VRNA) PT Raised to $44.00 - MarketBeat
Oct 9, 2024 · Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Verona Pharma presently has a consensus rating of Buy and an average price target of $39.33. Read Our Latest Report on Verona Pharma. Verona Pharma Stock Down 0.1 …
OFF
Verona Pharma (NASDAQ:VRNA) PT Raised To $44.00 - MarketBeat
2 weeks from now
Oct 9, 2024 · Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Verona Pharma presently has a consensus rating of Buy and an average price target of $39.33. Read Our Latest Report on Verona Pharma. Verona Pharma Stock Down 0.1 …
marketbeat.com
OFF
Verona Pharma (NASDAQ:VRNA) Sets New 1-Year High - Here's …
2 weeks from now
Dec 23, 2024 · Finally, Canaccord Genuity Group raised their price objective on Verona Pharma from $37.00 to $44.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Six analysts have rated the stock with a buy rating, According to MarketBeat, …
marketbeat.com
OFF
Verona Pharma (NASDAQ:VRNA) Receives “Buy” Rating ... - ETF …
2 weeks from now
4 days ago · Verona Pharma stock opened at $45.20 on Wednesday. The business has a 50 day moving average of $41.33 and a 200-day moving average of $31.52. The company has a market capitalization of $3.64 ...
etfdailynews.com
OFF
Verona Pharma (NASDAQ:VRNA) Raised To Strong-Buy At Roth …
2 weeks from now
3 days ago · Verona Pharma has a 12-month low of $11.39 and a 12-month high of $51.80. Verona Pharma (NASDAQ:VRNA – Get Free Report) last released its earnings results on Monday, November 4th. The company ...
defenseworld.net
OFF
Brokerages Set Verona Pharma Plc (NASDAQ:VRNA) Target Price …
2 weeks from now
Dec 20, 2024 · Shares of Verona Pharma stock opened at $41.22 on Tuesday. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of -21.47 and a beta of 0.46. The company has a debt-to ...
etfdailynews.com
OFF
Verona Pharma Price Target Raised To $57 From $44 At Truist
2 weeks from now
Jan 8, 2025 · Truist raised the firm’s price target on Verona Pharma (VRNA) to $57 from $44 and keeps a Buy rating on the shares. The firm cites the company’s positive Q4 revenue pre-announcement reflecting ...
nasdaq.com
OFF
Verona Pharma Price Target Raised To $74 From $64 At Wells Fargo
2 weeks from now
Jan 8, 2025 · Wells Fargo analyst Tiago Fauth raised the firm’s price target on Verona Pharma (VRNA) to $74 from $64 and keeps an Overweight rating on the shares. The firm notes preliminary Q4 sales of $36M ...
nasdaq.com
OFF
Verona Pharma (NASDAQ:VRNA) Reaches New 1-Year High
2 weeks from now
Dec 30, 2024 · Verona Pharma (NASDAQ:VRNA - Get Free Report) last released its earnings results on Monday, November 4th.The company reported ($0.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.44) by ($0.12). The firm had revenue of …
marketbeat.com
OFF
Verona Pharma (VRNA) Stock Price, News & Analysis - MarketBeat
2 weeks from now
2 days ago · About Verona Pharma Stock (NASDAQ:VRNA) ... 6 people have added Verona Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. ... Verona Pharma (VRNA) raised $61 million in an IPO on Thursday, …
marketbeat.com
OFF
4400 Liberty Ave, North Bergen, NJ 07047 - Zillow
2 weeks from now
4400 Liberty Ave, North Bergen NJ, is a Single Family home that contains 1972 sq ft and was built in 1916. The Zestimate for this Single Family is $664,300, which has decreased by $273 in the last 30 days.The Rent Zestimate for this Single Family is $3,457/mo, which has increased by …
zillow.com
OFF
VRNA News Today | Why Did Verona Pharma Stock Go Down …
2 weeks from now
5 days ago · Parkman Healthcare Partners LLC raised its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 5.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 626,452 shares of the company's stock …
marketbeat.com
OFF
Verona Pharma (NASDAQ:VRNA) Price Target Raised To $74.00
2 weeks from now
4 days ago · Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective boosted by Wells Fargo & Company from $64.00 to $74.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have an overweight rating on the stock. Other …
tickerreport.com
OFF
Verona Pharma (NASDAQ:VRNA) Price Target Raised To $74.00
2 weeks from now
5 days ago · Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price target raised by investment analysts at Wells Fargo & Company from $64.00 to $74.00 in a research report issued on Wednesday,Benzinga ...
etfdailynews.com
OFF
Verona Pharma (NASDAQ:VRNA) Sets New 12-Month High
2 weeks from now
Dec 16, 2024 · Verona Pharma plc (NASDAQ:VRNA - Get Free Report)'s stock price hit a new 52-week high on Monday . The stock traded as high as $43.57 and last traded at $43.22, with a volume of 148107 shares changing hands. The stock had previously closed at $41.42. VRNA …
marketbeat.com
FAQs about Verona Pharma (NASDAQ:VRNA) PT Raised to $44.00 - MarketBeat Coupon?
Is Verona Pharma a good stock to buy?
What percentage of Verona Pharma stock are owned by insiders?
Will Verona Pharma post earnings per share?
Should you buy Verona Pharma (vRNA)?
What was Verona Pharma's stock price on January 1st 2024?
Who owns Verona Pharma?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
